Literature DB >> 2540251

Immunized mice challenged with herpes simplex virus by the intranasal route show protection against latent infection.

J F Rooney1, C Wohlenberg, K J Cremer, A L Notkins.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2540251     DOI： 10.1093/infdis/159.5.974

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  3 in total

1.  Interference with major histocompatibility complex class II-restricted antigen presentation in the brain by herpes simplex virus type 1: a possible mechanism of evasion of the immune response.

Authors:  G A Lewandowski; D Lo; F E Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

2.  Immunization with a single major histocompatibility complex class I-restricted cytotoxic T-lymphocyte recognition epitope of herpes simplex virus type 2 confers protective immunity.

Authors:  J E Blaney; E Nobusawa; M A Brehm; R H Bonneau; L M Mylin; T M Fu; Y Kawaoka; S S Tevethia
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

3.  Efficacy of oral administration of live herpes simplex virus type 1 as a vaccine.

Authors:  H Irie; Y Harada; M Kataoka; M Nagamuta; Y Moriya; M Handa; M Saito; S Matsubara; K Kojima; Y Sugawara
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.